本页面由Tiger Trade Technology Pte. Ltd.提供服务

ENGENE HOLDINGS INC

1.56
-0.0200-1.27%
成交量:8.25万
成交额:12.81万
市值:1.04亿
市盈率:-0.77
高:1.57
开:1.55
低:1.55
收:1.58
52周最高:12.25
52周最低:1.40
股本:6,698.47万
流通股本:3,273.14万
量比:1.10
换手率:0.25%
股息:- -
股息率:- -
每股收益(TTM):-2.0205
每股收益(LYR):-2.2947
净资产收益率:-60.50%
总资产收益率:-31.99%
市净率:0.45
市盈率(LYR):-0.68

数据加载中...

公司资料

公司名字:
ENGENE HOLDINGS INC
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
4868 Rue Levy,Suite 220,Montreal,Quebec,Canada
邮编:
H4R 2P1
电话:
传真:
- -
简介:
enGene Therapeutics Inc.于2023年4月24日根据加拿大联邦法律注册为14963148 Canada Inc.。该公司是一家临床阶段的生物技术公司,通过向黏膜组织和其他器官提供治疗药物,将基因医学纳入主流,目标是创造新的方法来解决临床需求高的疾病,从非肌肉浸润性膀胱癌(NMIBC)开始。该公司正在开发基于其新型和专有的双重衍生的壳聚糖或“DDX”基因递送平台的非病毒基因疗法,该平台允许将多种基因货物直接本地化递送至黏膜组织和其他器官。

董事

名称
职位
Richard Glickman
Chairman and Independent Director
Ronald H. W. Cooper
Chief Executive Officer,Director and President
Gerald Brunk
Independent Director
Lota Zoth
Independent Director
Michael Heffernan
Independent Director
Paul Hastings
Independent Director
Philip Astley Sparke
Independent Director
William Grossman
Independent Director
Wouter Joustra
Independent Director

股东

名称
职位
Ronald H. W. Cooper
Chief Executive Officer,Director and President
Ryan Daws
Chief Financial Officer
Alex Nichols
Chief Strategy and Operations Officer
Amy Pott
Chief Global Commercialization Officer
Anthony T. Cheung
Chief Scientific Officer
Hussein Sweiti
Chief Medical Officer and Head of Research and Development
Jill Buck
Chief Development Officer
Joan Connolly
Chief Technology Officer
Lee G. Giguere
Chief Legal Officer and Corporate Secretary
Matthew Boyd
Chief Regulatory Officer